Literature DB >> 17150338

The role of host PrP in Transmissible Spongiform Encephalopathies.

Enrico Cancellotti1, Rona M Barron, Matthew T Bishop, Patricia Hart, Frances Wiseman, Jean C Manson.   

Abstract

PrP has a central role in the Transmissible Spongiform Encephalopathies (TSEs), and mutations and polymorphisms in host PrP can profoundly alter the host's susceptibility to a TSE agent. However, precisely how host PrP influences the outcome of disease has not been established. To investigate this we have produced by gene targeting a series of inbred lines of transgenic mice expressing different PrP genes. This allows us to study directly the influence of the host PrP gene in TSEs. We have examined the role of glycosylation, point mutations, polymorphisms and PrP from different species on host susceptibility and the disease process both within the murine species and across species barriers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17150338     DOI: 10.1016/j.bbadis.2006.10.013

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  14 in total

Review 1.  Allosteric function and dysfunction of the prion protein.

Authors:  Rafael Linden; Yraima Cordeiro; Luis Mauricio T R Lima
Journal:  Cell Mol Life Sci       Date:  2011-10-09       Impact factor: 9.261

2.  Dual conformation of H2H3 domain of prion protein in mammalian cells.

Authors:  Zhou Xu; Stéphanie Prigent; Jean-Philippe Deslys; Human Rezaei
Journal:  J Biol Chem       Date:  2011-09-12       Impact factor: 5.157

3.  Early behavioral changes and quantitative analysis of neuropathological features in murine prion disease: stereological analysis in the albino Swiss mice model.

Authors:  Roseane Borner; João Bento-Torres; Diego R V Souza; Danyelle B Sadala; Nonata Trevia; José Augusto Farias; Nara Lins; Aline Passos; Amanda Quintairos; José Antônio Diniz; Victor Hugh Perry; Pedro Fernando Vasconcelos; Colm Cunningham; Cristovam W Picanço-Diniz
Journal:  Prion       Date:  2011-07-01       Impact factor: 3.931

4.  Incomplete glycosylation during prion infection unmasks a prion protein epitope that facilitates prion detection and strain discrimination.

Authors:  Hae-Eun Kang; Jifeng Bian; Sarah J Kane; Sehun Kim; Vanessa Selwyn; Jenna Crowell; Jason C Bartz; Glenn C Telling
Journal:  J Biol Chem       Date:  2020-06-08       Impact factor: 5.157

5.  Mouse-adapted scrapie strains 139A and ME7 overcome species barrier to induce experimental scrapie in hamsters and changed their pathogenic features.

Authors:  Qi Shi; Bao-Yun Zhang; Chen Gao; Jin Zhang; Hui-Ying Jiang; Cao Chen; Jun Han; Xiao-Ping Dong
Journal:  Virol J       Date:  2012-03-09       Impact factor: 4.099

6.  The glycosylation status of PrPC is a key factor in determining transmissible spongiform encephalopathy transmission between species.

Authors:  Frances K Wiseman; Enrico Cancellotti; Pedro Piccardo; Kayleigh Iremonger; Aileen Boyle; Deborah Brown; James W Ironside; Jean C Manson; Abigail B Diack
Journal:  J Virol       Date:  2015-02-11       Impact factor: 5.103

7.  Trans-dominant inhibition of prion propagation in vitro is not mediated by an accessory cofactor.

Authors:  James C Geoghegan; Michael B Miller; Aimee H Kwak; Brent T Harris; Surachai Supattapone
Journal:  PLoS Pathog       Date:  2009-07-31       Impact factor: 6.823

8.  Distinct type of transmission barrier revealed by study of multiple prion determinants of Rnq1.

Authors:  Michele L Kadnar; Gulnara Articov; Irina L Derkatch
Journal:  PLoS Genet       Date:  2010-01-22       Impact factor: 5.917

Review 9.  Insights into Mechanisms of Chronic Neurodegeneration.

Authors:  Abigail B Diack; James D Alibhai; Rona Barron; Barry Bradford; Pedro Piccardo; Jean C Manson
Journal:  Int J Mol Sci       Date:  2016-01-12       Impact factor: 5.923

10.  Glycoform-independent prion conversion by highly efficient, cell-based, protein misfolding cyclic amplification.

Authors:  Mohammed Moudjou; Jérôme Chapuis; Mériem Mekrouti; Fabienne Reine; Laetitia Herzog; Pierre Sibille; Hubert Laude; Didier Vilette; Olivier Andréoletti; Human Rezaei; Michel Dron; Vincent Béringue
Journal:  Sci Rep       Date:  2016-07-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.